Matthew Kapusta has been named chief executive officer of uniQure NV, having served as interim CEO since September 2016 and as chief financial officer since January 2015. He was recruited to the top job at the gene therapy company following the departure of former CEO Daniel Soland.
Mr Kapusta has both life science and investment banking experience. Before joining uniQure he was senior vice president for business development at the medical device company AngioDynamics Inc. Prior to that, he was vice president for finance at Smith & Nephew Orthopaedics. He holds a Master of Business Administration degree from New York University’s Stern School of Business and is a certified public accountant. He worked in investment banking for more than a decade.
uniQure announced the appointment on 19 December 2016.
Copyright 2016 Evernow Publishing Ltd